Circulating neutrophils express the chemokine receptors CXCR1 and CXCR2, and their recruitment to tumour tissues is regulated by CXCL1 and CXCL2, which are the focus of several immune therapy strategies [20]. This evidence concerns the gene CXCL2 and neoplasm.